13F-HR filed by Jones Hill Capital LP
Jones Hill Capital LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 15:12:59 UTC, with 33 holding rows worth $589,169,587.
- Accession
- 0002102314-26-000006
- Filer
- CIK 2102314
- Filed
- 2026-11-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 33 entries on the cover page, a total value of $589,169,587 stated on the cover page (in dollars after the unit check, H1), rows summing to $589,169,587 with VALUE read as dollars as filed, 13F file number 028-26921. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 1,171,859 | $70,311,540 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 7,083,300 | $59,003,889 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 959,634 | $56,503,250 | dollars as filed | |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | COM | 1,526,685 | $54,731,657 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 987,637 | $31,327,846 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 382,901 | $30,448,288 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 599,826 | $26,782,231 | dollars as filed | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 601,685 | $25,896,522 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 4,486,986 | $25,127,122 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 652,218 | $21,060,119 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,447,156 | $20,723,274 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 1,064,233 | $19,805,376 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 5,237,628 | $19,745,858 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 142,558 | $14,116,093 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,504,651 | $13,174,464 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 106,528 | $12,159,106 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 83,426 | $11,833,144 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 384,278 | $11,639,781 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 610,118 | $8,944,330 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 892,532 | $8,452,278 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 80,017 | $7,045,497 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 217,700 | $6,056,414 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 886,428 | $6,045,439 | dollars as filed | |
| TONIX PHARMACEUTICALS HOLDIN | 890260839 | COMMON STOCK | 563,739 | $5,490,818 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 502,587 | $4,965,560 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 300,900 | $4,847,499 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 126,744 | $3,610,937 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 182,295 | $3,124,536 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 276,830 | $2,020,859 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 593,737 | $2,006,831 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 206,397 | $1,783,270 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 122,169 | $230,899 | dollars as filed | |
| ALVOTECH | L01800108 | ORDINARY SHARES | 26,700 | $154,860 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002102314-26-000006 | this filing | 2026-11-13 |